Vivek Kaimal

Statistics

Publications

Citations

H-Index

Active since

2008

Affiliations

Regulus Therapeutics (United States)(Current)

Cincinnati Children's Hospital Medical Center

University of Cincinnati Medical Center

Harvard University

University of Michigan

Vivek Kaimal is an author at Regulus Therapeutics (United States) specializing in microrna biology, gene expression, and microrna-mediated regulation.

ORCID

Publications per year

2008–2017

Publications

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

Katey J. Rayner, Christine Esau, Farah Hussain et al. · Nature · 2011 · 697 citations · Full text

Life Sciences, Molecular Biology, Physiology +12

MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

B. Nelson Chau, Cuiyan Xin, Jochen C. Hartner et al. · Science Translational Medicine · 2012 · 581 citations

Medicine, Molecular Biology, Nephrology +12

Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit

Thomas Bertero, Katherine A. Cottrill, Yu Lu et al. · Cell Reports · 2015 · 234 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +13

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism

Sachin Hajarnis, Ronak Lakhia, Matanel Yheskel et al. · Nature Communications · 2017 · 207 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Staging of biliary atresia at diagnosis by molecular profiling of the liver

Katie Moyer, Vivek Kaimal, Cristina Pacheco et al. · Genome Medicine · 2010 · 84 citations · Full text

Medicine, Molecular Medicine, Pathology +17

1–5 of 11